Universitätsklinik Erlangen

Erlangen 91054

1 studies enrolling now · 4 studies all time

What they study most

Extra-Pancreatic Neuroendocrine Tumor (epNET), Heart Failure, High-risk Large B-cell Lymphoma (LBCL), Locally Advanced or Unresectable Metastatic Breast Cancer, Pancreatic Neuroendocrine Tumor (pNET), Stage IV Breast Cancer

Studies at this site

• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors — Recruiting now
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads — Stopped early